文献速递口腔修复与种植牙周病

种植体周病的原发性和一级预防:系统综述与meta分析

Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis.
PubMed 文献 · J Clin Periodontol · 2023-03-06

该系统综述与meta分析评估风险因素控制对预防种植体周病(PIDs)的疗效,纳入48项随访至少6个月的研究。未发现评估原发性预防措施的研究;间接证据表明,血糖控制良好的糖尿病患者种植体周炎风险较低(OR=0.16),定期支持性牙周/种植体周维护(SPC)与较低的PIDs风险相关(OR=0.42),种植体周角化黏膜(PIKM)增量术与较低的种植体周炎症和边缘骨水平(MBL)变化相关。

要点

  • 血糖控制良好的糖尿病患者种植体周炎风险显著低于控制不佳者(OR=0.16)。
  • 定期SPC患者总体PIDs风险低于不定期者(OR=0.42),种植体失败风险在不定期或无SPC时更高(OR=3.76)。
  • PIKM增量术与较低的种植体周炎症和MBL变化相关,吸烟戒断和口腔卫生行为研究无定论。

核心结论

  • 在现有证据的局限性内,糖尿病患者应促进血糖控制以避免种植体周炎发生。
  • 种植体周炎的一级预防应包括定期SPC。
  • 存在PIKM不足时,PIKM增量术可能有利于控制种植体周炎症和MBL稳定。
  • 需要进一步研究评估吸烟戒断和口腔卫生行为的影响,以及实施标准化的原发性和一级预防方案。

研究设计与样本

  • 系统综述与meta分析,检索截至2022年8月,无时间限制,纳入干预性和观察性研究,随访至少6个月。
  • 共纳入48项研究,采用随机效应模型进行汇总数据分析。

主要发现

  • 无研究评估原发性预防干预对PIDs的疗效。
  • 血糖控制良好的糖尿病患者与控制不佳者相比,种植体周炎风险显著较低(OR=0.16;95%CI:0.03-0.96;I2=0%),MBL变化较低(OR=-0.36 mm;95%CI:-0.65至-0.07;I2=95%)。
  • 定期SPC患者与不定期者相比,总体PIDs风险较低(OR=0.42;95%CI:0.24-0.75;I2=57%),种植体周炎风险较低。
  • 不定期或无SPC时种植体失败风险高于定期SPC(OR=3.76;95%CI:1.50-9.45;I2=0%)。
  • PIKM增量术位点与PIKM不足者相比,种植体周炎症较低(SMD=-1.18;95%CI:-1.85至-0.51;I2=69%),MBL变化较低(MD=-0.25;95%CI:-0.45至-0.05;I2=62%)。

关键数值与推荐

  • 糖尿病患者血糖控制良好者种植体周炎OR=0.16(95%CI:0.03-0.96;I2=0%),MBL变化OR=-0.36 mm(95%CI:-0.65至-0.07;I2=95%)。
  • 定期SPC者总体PIDs OR=0.42(95%CI:0.24-0.75;I2=57%)。
  • 不定期或无SPC者种植体失败OR=3.76(95%CI:1.50-9.45;I2=0%)。
  • PIKM增量术位点种植体周炎症SMD=-1.18(95%CI:-1.85至-0.51;I2=69%),MBL变化MD=-0.25(95%CI:-0.45至-0.05;I2=62%)。

临床怎么用

  • 对糖尿病患者,应促进血糖控制以降低种植体周炎风险。
  • 将定期SPC作为种植体周炎一级预防的组成部分。
  • 存在PIKM不足时,可考虑PIKM增量术以利于控制种植体周炎症和MBL稳定。
  • 吸烟戒断和口腔卫生行为的证据尚不明确,需进一步研究。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: This systematic review and meta-analysis aims to assess the efficacy of risk factor control to prevent the occurrence of peri-implant diseases (PIDs) in adult patients awaiting dental implant rehabilitation (primordial prevention) or in patients with dental implants surrounded by healthy peri-implant tissues (primary prevention). MATERIALS AND METHODS: A literature search was performed without any time limit on different databases up to August 2022. Interventional and observational studies with at least 6 months of follow-up were considered. The occurrence of peri-implant mucositis and/or peri-implantitis was the primary outcome. Pooled data analyses were performed using random effect models according to the type of risk factor and outcome. RESULTS: Overall, 48 studies were selected. None assessed the efficacy of primordial preventive interventions for PIDs. Indirect evidence on the primary prevention of PID indicated that diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16; 95% confidence interval [CI]: 0.03-0.96; I2 : 0%), and lower marginal bone level (MBL) changes (OR = -0.36 mm; 95% CI: -0.65 to -0.07; I2 : 95%) compared to diabetic patients with poor glycaemic control. Patients attending supportive periodontal/peri-implant care (SPC) regularly have a lower risk of overall PIDs (OR = 0.42; 95% CI: 0.24-0.75; I2 : 57%) and peri-implantitis compared to irregular attendees. The risk of dental implant failure (OR = 3.76; 95% CI: 1.50-9.45; I2 : 0%) appears to be greater under irregular or no SPC than regular SPC. Implants sites with augmented peri-implant keratinized mucosa (PIKM) show lower peri-implant inflammation (SMD = -1.18; 95% CI: -1.85 to -0.51; I2 : 69%) and lower MBL changes (MD = -0.25; 95% CI: -0.45 to -0.05; I2 : 62%) compared to dental implants with PIKM deficiency. Studies on smoking cessation and oral hygiene behaviors were inconclusive. CONCLUSIONS: Within the limitations of available evidence, the present findings indicate that in patients with diabetes, glycaemic control should be promoted to avoid peri-implantitis development. The primary prevention of peri-implantitis should involve regular SPC. PIKM augmentation procedures, where a PIKM deficiency exists, may favour the control of peri-implant inflammation and the stability of MBL. Further studies are needed to assess the impact of smoking cessation and oral hygiene behaviours, as well as the implementation of standardized primordial and primary prevention protocols for PIDs.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Carra MC, Blanc-Sylvestre N, Courtet A, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023. PMID: 36807599. doi:10.1111/jcpe.13790

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。